miproducts
SPECIAL PROMOTION
Optimel Manuka+ for Eye Hygiene
Optimel’s Manuka+ range helps restore eye comfort and reduce inflammation. Made with Manuka honey, Optimel’s treatments aid eye lid-margin hygiene, with a low pH environment limiting bacterial growth.
Optimel Manuka+ Dry Eye Drops for mild to moderate dry eye help stabilise the surface health of the eye, providing relief from dry eye symptoms such as sore, irritated eyes and eye lids.
Optimel Manuka+ Forte Eye Gel for moderate to severe dry eye contains 98% honey with increased viscosity and is preservative free.
Optimel Manuka+ Eyelid Cream is a low pH emollient cream containing honey and Jojoba oil to restore the skin’s natural structure. It is also effective in treating atopic dermatitis.
Contact: OphthalmoPro (AUS) 1300 578 288
wavelight plus for Refractive Treatment
wavelight plus* is the first fully tailored refractive treatment that accounts for the unique optical system of each person, including the cornea, anterior chamber, and crystalline lens.1
The wavelight plus all-in-one Sightmap diagnostic device combines biometry, tomography, and wavefront to create a virtual 3D eye model and individualised treatment plan.1
Even complex cases can now achieve better than 20/20 vision,2 unlocking a new world of possibilities for both patients and surgeons.
Contact: Alcon Surgical Representative
*wavelight plus is the alternative equivalent tradename for InnovEyes treatment.
References
1. Mrochen, M., Bueler, M., Donitzky, C., Seiler, T. Optical ray tracing for the calculation of optimized corneal ablation profiles in refractive treatment planning.
J Refract Surg. 2008 Apr;24(4):S446–51. DOI: 10.3928/1081597X-20080401-23.
2. Alcon data on file, 2021. RFP911-P001 Postmarket study of outcomes from wavelight EX500 InnovEyes - V-RIM-0063613.
Alcon Discontinues Two Dry Eye Produ
Alcon has discontinued two of its dry eye products – Bion Tears and Poly Gel, which are no longer available via the Australian Pharmaceutical Benefits Scheme (PBS). In a statement Alcon said it leverages European Union (EU) registration with the Therapeutic Goods Administration (TGA) for marketing Bion Tears and Poly Gel in Australia.
“Due to EU regulatory changes, Alcon has made the difficult decision to discontinue Bion Tears and Poly Gel from Europe and the Australian and New Zealand market,” the company said.
Alternate Recommendations
As well as PBS-listed options, Alcon also supplies the Systane suite of
products to help manage dry eye symptoms.
Contact: Alcon Sales Representative